Schadendorf, D., R. Dummer, A. Hauschild, M. Santinami, V. Atkinson, M. Mandala, V. Chiarion-Sileni, J. Larkin, M. Nyakas, C. Dutriaux, A. Haydon, L. Mortier, C. Robert, J. Schachter, C.-E. Ortmann, E. de Jong, E. Gasal, R. Kefford, J. M. Kirkwood, and G. V. Long. “Association Between Baseline Disease Characteristics and Relapse-Free Survival in Patients With BRAF V600–Mutant Resected Stage III Melanoma Treated With Adjuvant Dabrafenib + Trametinib or Placebo”. SKIN The Journal of Cutaneous Medicine, vol. 3, Nov. 2019, p. S53, doi:10.25251/skin.3.supp.53.